NCT03036280: A trial that was reported late by Eisai Co., Ltd.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT03036280 |
|---|---|
| Title | A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study With an Open-Label Extension Phase to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 29, 2016 |
| Completion date | Nov. 21, 2023 |
| Required reporting date | Nov. 20, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 12, 2021 |
| Days late | None |